Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

GNOMvsGNMXETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
+3.8%
VS
ETF 2
GNMX

Corgi Genomics & Precision Medicine ETF

This fund is part of
BioTech & Genomics
+3.8%

Global X Genomics & Biotechnology ETF (GNOM) and Corgi Genomics & Precision Medicine ETF (GNMX) belong to the same industry segment: BioTech & Genomics. GNOM's top 3 sector exposures are Healthcare and Industrials. In contrast, GNMX's top sector exposures are Healthcare  GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of GNOM and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs GNMX performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Jun 30Jul 7Jul 14Jul 21Jul 28

Cumulative Flows

02,000,0004,000,0006,000,0008,000,00010,000,000Jun 30Jul 7Jul 14Jul 21Jul 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
GNMX
-2.19%-2.44%
+22.58%+18.01%
+21.83%n/a
+58.30%n/a
+14.80%n/a
-38.54%n/a
Flows
GNOM
GNMX
+$7M-
+$19M+$1M
+$18M-
+$13M-
-$95M-
-$862K-
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
GNMX
+28.16%+27.51%
+26.78%n/a
+29.11%n/a
+33.32%n/a
Max drawdown
GNOM
GNMX
-8.57%-8.53%
-18.16%n/a
-43.10%n/a
-72.01%n/a
Max drawdown duration
GNOM
GNMX
24d24d
145dn/a
674dn/a
1792dn/a
Trading data

Create an account to view trading data

Join for free
GNOM
GNMX
Last sale
7/31/2026 at 3:22 PM
$53.88
Previous close
07/30/2026
$55.39
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

GNMX
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
GNOM
GNMX
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 3:22 PM
Live
Closed
GNOM
GNMX
Last price
$53.88
1D performance
-2.73%
AuM$81.18 M$1.67 M
E/R0.5%0.35%
Characteristics
GNOM
GNMX
Management strategyPassiveActive
ProviderGlobal XCorgi Funds
BenchmarkSolactive Genomics Index-
N° of holdings5057
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019May 6, 2026
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
84.1%
Other
15.9%
GNMX
USA
89.37%
Other
10.63%

Sectors

GNOM
Healthcare
99.75%
Other
0.25%
GNMX
Healthcare
98.21%
Other
1.79%

Diversification

GNOM

Total weight of top 15 holdings out of 15

61.22%
GNMX

Total weight of top 15 holdings out of 15

53.1%

Top 15 holdings

Data as of June 30, 2026
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
Frequently asked questions about GNOM and GNMX

Which ETF is bigger: GNOM or GNMX?

As of July 30, 2026, GNOM holds $81.18 M in assets under management (AUM), while GNMX manages $1.67 M.

What sectors do the GNOM and GNMX ETFs invest in?

GNOM leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.

What are the top holdings of the GNOM ETF and GNMX ETF?

GNOM top holdings include Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc..

Which ETF is more diversified: GNOM or GNMX?

GNOM holds 50 securities with 61.22% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 53.1%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026